That's essential, due to the fact that the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and be efficient. Simply put, we need to understand how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error process (genetic sequencing companies jeff brown). Now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to produce drugs that do what they're developed to do. This was a breakthrough nearly no one noticed. However it's going to have extensive implications for treating disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be lots of investment chances in this area, too. Moving subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown investment prediction). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it drew back perhaps considerably before going greater - artificial intelligence. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were mainly informing readers. However that's not the huge question any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. jeff brown genetic sequencing stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are so many great personal business on the edge of striking the public markets And I have actually been working on a new method for you to invest even before these business go public.
This chance has been developing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the details. Go right here to schedule your spot free of charge.
Emma Walsh here, handling editor of the Diary. Routine Diary readers know that tech isn't our normal beat (last year). And when it pertains to tech investing, we leave it to the experts. The good news is, we have a number of such experts in our Rolodex. Our coworker Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing experts we understand (black sea). In truth, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and predict what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These trends are experiencing rapid development and producing amazing chances for investors. I want to ensure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. melania trump. But despite what lots of readers may think, this is a pattern that's just starting. Although the COVID-19 pandemic interfered with supply chains in 2015, an outstanding 250 million 5G-enabled devices were still sold.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (brownstone research stock). Losing 2 months of production and sales really affects how many 5G devices are offered in the fiscal year. When you consider all of that, offering 250 million units is impressive. More importantly, the delays triggered by the pandemic created a lots of pent-up need. And that demand is now going to be pressed into 2021. In reality, I predict that more than 500 million 5G gadgets will be shipped in 2021 - biotech stocks. And that's not my only 5G prediction When I have actually talked about 5G in the past, I have actually described its three different stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Phase 3, 5G services begin to be used (jeff brown prediction for 2021). That's when we begin to see applications operating on 5G networks. Believe of things like huge multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Stage 3 by this summer season. This begins something of a virtuous cycle: Many people don't actually care about the innovation. However they will care if there are interesting applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In reality, 5G is going to open a suite of extraordinary applications: self-driving vehicles, the Web of Things, robotic surgical treatment, and more. All of these innovations need 5G. The financial investment chances going forward will be massive. Stepping away from 5G, the next crucial technology I foresee in 2021 is CRISPR genetic modifying. CRISPR means "clustered frequently interspaced short palindromic repeat." It's a mouthful. However it is among the most interesting developments in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not work correctly. CRISPR uses a similar idea but with our genetic code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For many years, CRISPR was mostly a specific niche innovation that wasn't well comprehended. And throughout that time, there were actually only three business operating in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this innovation just works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and delivering amazing returns. This whole market is efficiently a greenfield chance.
There's room for many companies to exist in this area. jeff brown. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or three more hereditary editing companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things happening at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software application can precisely predict the folding of a protein based exclusively on its amino acid sequence with 92. 4% precision. That is essential since the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be effective.
Historically, this has actually been a trial-and-error process. And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one but a number of drug therapies produced utilizing this technology. This was among those developments that practically nobody observed. But it's going to have extensive implications for curing disease. And, of course, there will be lots of investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it pulled back maybe significantly prior to going higher. I have actually been covering bitcoin for a very long time now. Among the very first research reports I ever released was on bitcoin - jeff brown latest prediction. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. However at the time of that preliminary recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
However no one is asking that question any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. exponential growth. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the information depends on date as of February 2021, but we might not individually confirm this claim. Given Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like ability to select winning innovation stocks. He invested more than 25 years researching innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an outstanding point of view on the market. He's constantly on the hunt for new chances, and he shares a number of his finest choices in the Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an exceptional credibility as a stock-picker, and he successfully forecasted a few of the biggest financial events of the past 20 years. Although he does not appear to launch his picks to the general public, the service's success is a direct indication of Brown's stock-picking expertise. Nobody on Wall Street gets it best every time, but Jeff Brown's precise forecasts have actually made him legions of devoted followers. That says a lot about his capability. The Future Report is released by Brownstone Research study, a popular monetary research study publisher. Brownstone Research provides several research study services with a broad variety of expertises - diplomatic relations.
The business is likewise associated with Bonner & Partners, another well-respected research publisher - future report. On its website, Brownstone says its mission is to offer retail financiers with professional-grade research: "For too long, the very best investment research has not been available to specific investors. It has been usually booked for financial investment banks, hedge funds, private equity, and high-net-worth clients. angel investor. The objective of Brownstone Research is to make that sort of exclusive research offered to any investors looking to acquire an edge in the marketplaces. The goal is easy to deliver unique and rewarding investment research study discovered no place else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise acts as the company's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to offer its clients. After years of stable success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout many of America. If you know even a bit about the market, you understand that he has a reputation as a King Midas of sorts. jeff brown top stock pick 2021. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In truth, Brown believes S.A.V. second wave. might be "the most significant pattern of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying 2 innovative technologies: artificial intelligence and electrical vehicles. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving vehicles ever. It's nothing except the automotive market's Holy Grail. As you understand, electric lorries and self-driving car stocks have been big this year, but the Wall Street device has been big on buzz without much tangible outcome. Despite a drastic boost in competitors over the past couple of years, Brown still thinks Musk has the best opportunity of putting all of it together.
tech might be the magic string that ties everything together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transportation. Basically, this innovation would allow you to rent your car as an autonomous, self-driving taxi when you're not utilizing it. You merely get out of the cars and truck and press a button on an app that informs the cars and truck to "sign up with the fleet." Next thing you understand, you're relaxing on your sofa while your car shuttles ride-sharers around town. Best of all, you get to keep a large piece of the earnings. It sounds outrageous, however it could be closed than you think.